TLR9 and vitiligo: In line with the important role of IFNα in disease pathogenesis, hydroxychoroquine, a TLR7 and TLR9 inhibitor downregulating IFNα production by pDCs, was shown to induce repigmentation of vitiligo lesions in a clinical case reports (64, 65).